Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0034063 (
pulmonary edema
)
10,665
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Sphingomyelin synthase (SMS) catalyzes the synthesis of sphingomyelin (SM) and is required for maintenance of plasma membrane microdomain fluidity. Of the two isoforms of mammalian SMS,
SMS1
is mostly present in the trans-Golgi apparatus, whereas
SMS2
is predominantly found at the plasma membrane.
SMS2
has a role in receptor mediated response to inflammation in macrophages, however, the role of
SMS2
in vascular permeability,
pulmonary edema
, and lung injury have not been investigated. To define the role of SMS activation in lung injury, we utilized a lipopolysaccharide (LPS)-induced
lung edema
model. SMS activity was measured and correlated with the severity of lung injury. Within 4 h of LPS treatment, SMS activity was increased significantly and remained upregulated up to 24 h. Comparison of LPS-induced lung injury in
SMS2
knockout (
SMS2
(-/-)) and wild-type littermate control mice showed that inflammation, cytokine induction, and lung injury were significantly inhibited in
SMS2
(-/-) mice. Our results suggest that a deficiency of
SMS2
can diminish the extent of
pulmonary edema
and lung injury. Furthermore, we show that depletion of
SMS2
was sufficient to decrease MAP kinase-JNK activation, severity of LPS-induced pulmonary neutrophil influx, and inflammation, suggesting a novel role of
SMS2
activation in lung injury.
...
PMID:Sphingomyelin synthase 2 (SMS2) deficiency attenuates LPS-induced lung injury. 2119 Nov 8